Founder of Ebb™ Therapeutics and a board-certified sleep physician, Eric Nofzinger, M.D. is passionate and dedicated to finding successful sleep solutions. Dr. Nofzinger conducted brain imaging studies that led to identifying a breakthrough solution to treat insomnia. By gently cooling the forehead with a precise, clinically-proven therapeutic range, Ebb Insomnia Therapy reduces activity in the frontal cortex (part of the brain behind the forehead) to help calm racing thoughts and get people to sleep quicker without unwanted side-effects.
Ebb Therapeutics called on Tactile to help design Ebb Insomnia Therapy—the first and only FDA-cleared medical device to treat people with insomnia by reducing latency to Stage 1 sleep (the first stage of sleep) and Stage 2 sleep (the second stage and deeper stage that typically represents about half the night).